Contemporary OB/GYN week in review: pediatric STIs, postpartum depression, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: pediatric STIs, postpartum depression, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, May 6 - Friday, May 10 2024), and click each link to read and watch anything you may have missed.
1.) Understanding pediatric STIs: Trends, management, and more
Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Click here for the full article.
2.) Impact of weight, ferritin, and nutrition education on postpartum depression risk
A recent study highlights the role of weight gain, ferritin levels, and nutritional education in influencing the risk of postpartum depression among pregnant women, urging for proactive measures during routine prenatal care.
Click here for the full article.
3.) Pioglitazone outperforms metformin in IVF for PCOS-related infertility
A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Click here for the full article.
4.) Barriers in seeking pelvic floor disorder treatment among ethnic minorities
A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Click here for the full article.
5.) Fertility counseling for oncology patients
Elina Melik-Levine, ARNP, highlights the importance of early discussions about fertility preservation, referral pathways, and addressing socioeconomic challenges in cancer care, emphasizing the role of Miami Cancer Institute's onco-fertility program.
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
